Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Serotonin 6 receptor (5-HT6 receptor) is a G protein-coupled receptor highly expressed in the central nervous system, where it modulates neurotransmission, cognition, learning, and mood, and is a therapeutic target for psychiatric and neurodegenerative disorders[1][3]. The Adrenergic receptors are a family of G protein-coupled receptors (including alpha and beta subtypes) that respond to catecholamines (epinephrine, norepinephrine) and mediate effects in the cardiovascular system, smooth muscle, metabolism, and central and peripheral nervous system. They are primary targets for drugs treating hypertension, heart failure, asthma, and anxiety disorders[3].
Serotonin 6 receptor: Agonism or antagonism, usually CNS-selective, leading to modulation of cAMP signaling via Gs protein coupling, affecting cognition, mood, feeding. Adrenergic receptors: Agonism or antagonism, modulating G protein-coupled signaling (Gs, Gi/o, Gq/11) to affect heart rate, vascular tone, smooth muscle contraction/relaxation, neurotransmitter release
10 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serotonin 6 receptor and Adrenergic receptor (5-HT6 receptor and Adrenergic receptor).